P F
1 jun, 2020

Pharmacy clinical authorizations extensions due to COVID-19

Due to the COVID-19 pandemic, BCBSRI has extended all clinical authorization approvals by Prime Therapeutics as stated below:

Commercial

  • Existing clinical prior authorizations for pharmacy drugs with an original expiration date between 31 de marzo de 2020 and 30 de junio de 2020 have been extended 90 days from the original expiration date to reduce provider and member burden. Restrictions may apply.
  • Early refill restrictions are lifted through 30 de junio de 2020. Restrictions may apply.

Medicare

  • Existing clinical prior authorizations for pharmacy drugs with an original expiration date between 23 de marzo de 2020 and 30 de mayo de 2020 have been extended 60 days from the original expiration date to reduce provider and member burden. Restrictions may apply.
  • Early refill restrictions are lifted through 30 de junio de 2020. Restrictions may apply.